~Thyroid Regulation - References


1. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997 Sep;12(9):544-50.

2. Leonard Wartofsky. Management of Subclinical Hyperthyroidism. J. Clin. Endocrinol. Metab. 2011 96: 59-61

3. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism. J Clin Endocrinol Metab. 2011 Feb 23.

4. Boonya-Ussadorn T, Punkaew B, Sriassawaamorn N. A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women. J Med Assoc Thai. 2010 Nov;93 Suppl 6:S1-5.

5. Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE, Raptis SA. Effect of Hyperthyroidism on Clearance and Secretion of Glucagon in Man. Exp Clin Endocrinol Diabetes. 2011 Jan 24.

6. Leonard Wartofsky. Management of Subclinical Hyperthyroidism. J. Clin. Endocrinol. Metab. 2011 96: 59-61

7. Videla LA, Fernández V, Tapia G, Varela P. Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front Biosci. 2007 Jan 1;12:1220-8.

8. Pearce EN. National trends in iodine nutrition: is everyone getting enough? Thyroid. 2007 Sep;17(9):823-7.

9. Segerson TP, Kauer J, Wolfe HC, et al. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science. 1987 Oct 2;238(4823):78-80.

10. Dyess EM, Segerson TP, Liposits Z, et al. Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology. 1988 Nov;123(5):2291-7.

11. Arancibia S, Rage F, Astier H, Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology. 1996 Oct;64(4):257-67.

12. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002 Oct;53(4):865-71.

13. Roelfsema F, Pereira AM, Biermasz NR, et al. Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome. Eur J Endocrinol. 2009 Nov;161(5):695-703.

14. Angermayr L, Clar C. Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database Syst Rev. 2004;(2):CD003819.

15. Kelly GS. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 2000 Aug;5(4):306-33.

16. Köhrle J. Thyroid hormone deiodinases--a selenoenzyme family acting as gate keepers to thyroid hormone action. Acta Med Austriaca. 1996;23(1-2):17-30.

17. Nussey S, Whitehead S. Endocrinology: An Integrated Approach. Oxford: BIOS Scientific Publishers; 2001. Box 3.28. Available at:http://www.ncbi.nlm.nih.gov/books/NBK28/

18. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001 Jun 7;344(23):1743-9.

19. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011 Jan;96(1):E1-8.

20. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006 Dec;35(4):663-86

21. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993 Jun;22(2):263-77.

22. Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol. 2011 Feb 17.

23. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006 Dec;35(4):663-86, vii.

24. Streetman DD, Khanderia U. Diagnosis and treatment of Graves disease. Ann Pharmacother. 2003 Jul-Aug;37(7-8):1100-9.

25. Sinclair C, Gilchrist JM, Hennessey JV, Kandula M. Muscle carnitine in hypo- and hyperthyroidism. Muscle Nerve. 2005 Sep;32(3):357-9.

26. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2001 Aug;86(8):3579-94.

27. Deng J, Zhou Y, Bai M, Li H, Li L. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa.J Ethnopharmacol. 2010 Mar 2;128(1):148-53.

28. Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.Med Sci Monit. 2009 Nov;15(11):RA256-62.

29. Hypothyroidism. The American Thyroid Association. http://www.thyroid.org/patients/brochures/Hypo_brochure.pdf Accessed March 18, 2011.

30. Garduńo-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010 Aug;163(2):273-8.

31. Dayan CM, Saravanan P, Bayly G. Whose normal thyroid function is better—yours or mine? Lancet. 2002 Aug 3;360(9330):353.

32. Garduno-Garcia Jde J et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010 Aug;163(2):273-8.

33. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician. 2005 Oct 15;72(8):1517-24.

34. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 Dec;7(6):481-93.

35. Okosieme OE, Belludi G, Spittle K, Kadiyala R, Richards J. Adequacy of thyroid hormone replacement in a general population. QJM. Epub 2010 Nov 24.

36. Ebert EC. The thyroid and the gut. J Clin Gastroenterol. 2010 Jul;44(6):402-6.

37. Romaldini JH, Sgarbi JA, Farah CS. Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism. Arq Bras Endocrinol Metabol. 2004 Feb;48(1):147-58.

38. Hennessey JV, Scherger JE. Evaluating and treating the patient with hypothyroid disease. J Fam Pract. 2007 Aug;56(8 Suppl Hot Topics):S31-9.

39. Cole DP, Thase ME, Mallinger AG, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry. 2002 Jan;159(1):116-21.

40. Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology. 2008 Aug;33(7):1013-22.

41. Samuels MH, Schuff KG, Carlson NE, et al. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab. 2007 Jul;92(7):2545-51.

42. Anjana Y, Tandon OP, Vaney N, Madhu SV. Cognitive status in hypothyroid female patients: event-related evoked potential study. Neuroendocrinology. 2008;88(1):59-66.

43. Kritz-Silverstein D, Schultz ST, Palinska LA, Wingard DL, Barrett-Connor E. The association of thyroid stimulating hormone levels with cognitive function and depressed mood: the Rancho Bernardo study. J Nutr Health Aging. 2009 Apr;13(4):317-21.

44. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004 Aug;61(2):232-8.

45. Duntas LH, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost. 2011 Feb;37(1):27-34.

46. Saito I, Ito K, Saruta T. Hypothyroidism as a cause of hypertension. Hypertension. 1983 Jan-Feb;5(1):112-5.

47. Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1559-65.

48. Duntas LH. Thyroid disease and lipids. Thyroid. 2002 Apr;12(4):287-93.

49. Rodondi N, den Elzen WPJ, Bauer DC, et al. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA. 2010;304(12):1365-1374.

50. Stamatelopoulos KS, Kyrkou K, Chrysochoou E, et al. Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto's thyroiditis: The effect of menopausal status. Thyroid. 2009 Aug;19(8):857-62.

51. Caparević Z, Bojković G, Stojanović D, Ilić V. Dyslipidemia and subclinical hypothyroidism. Med Pregl. 2003 May-Jun;56(5-6):276-80.

52. Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol. 1997 Mar;13(3):273-6.

53. Bicíková M, Hampl R, Hill M, et al. Steroids, sex hormone-binding globulin, homocysteine, selected hormones and markers of lipid and carbohydrate metabolism in patients with severe hypothyroidism and their changes following thyroid hormone supplementation. Clin Chem Lab Med. 2003 Mar;41(3):284-92.

54. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003 Feb;166(2):379-86.

55. Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, et al. The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J. Epub 2010 Nov 30.

56. Joshi JV, Bhandarkar SD, Chadha M, et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med. 1993 Jul-Sep;39(3):137-41.

57. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf). 2007 Mar;66(3):309-21.

58. Doucet J, Trivalle C, Chassagne P, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994 Sep;42(9):984-6.

59. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65-71.

60. Guan H, Shan Z, Teng X, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf). 2008 Jul;69(1):136-41..

61. American Association of Clinical Endocrinologists. Subclinical thyroid disease. http://www.aace.com/pub/positionstatements/subclinical.php. Accessed March 17, 2011.

62. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005 Sep;90(9):5483-8.

63. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003 Jan;13(1):3-126.

64. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM et al. Low serum thyrotropin (thyroid stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991;151:165-8.

65. Parle JV, Maisonneuve P, Sheppard MC, Boyle P and Franklyn JA. Prediction of all-cause andcardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year study.Lancet 2001Sept 15;358:861-5.

66. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006 Jun 29;354(26):2783-93.

67. Meyerovitch J, Rotman-Pikielny P, Sherf M, et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med. 2007 Jul 23;167(14):1533-8.

68. Sehnert KW, Croft AC. Basal metabolic temperature vs. laboratory assessment in "posttraumatic hypothyroidism". J Manipulative Physiol Ther. 1996 Jan;19(1):6-12.

69. Mastorakos G, Pavlatou M. Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes. Horm Metab Res. 2005 Sep;37(9):577-84.

70. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002 Oct;53(4):865-71.

71. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's Thyroiditis. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:205-11; discussion 211.

72. Meloni A, Mandas C, Jores RD, Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr. 2009 Jul;155(1):51-5, 55.e1.

73. Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2009 Dec;103(6):496-501.

74. Aamir IS, Tauheed S, Majid F, Atif A. Frequency of autoimmune thyroid disease in chronic urticaria. J Coll Physicians Surg Pak. 2010 Mar;20(3):158-61.

75. Kiyici S, Gul OO, Baskan EB, et al. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 2010 Aug;35(6):603-7.

76. Tohei A. et al J Reprod Dev. Studies on the functional relationship between thyroid, adrenal and gonadal hormones. 2004 Feb;50(1):9-20.

77. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician. 2005 Oct 15;72(8):1517-24.

78. Jordan RM. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am. 1995 Jan;79(1):185-94.

79. The NationalWomen’s Health Information Center. http://www.womenshealth.gov/faq/thyroid-disease.cfm. Accessed March 17, 2011.

80. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's Thyroiditis. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:205-11; discussion 211.

81. Paknys G, Kondrotas AJ, Kevelaitis E. Risk factors and pathogenesis of Hashimoto's thyroiditis. Medicina (Kaunas). 2009;45(7):574-83.

82. McLachlan SM, Nagayama Y, Pichurin PN, et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology. 2007 Dec;148(12):5724-33.

83. Selenkow HA, Wyman P, Allweiss P. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases. Compr Ther. 1984 Apr;10(4):48-56.

84. Wasniewska M, Corrias A, Arrigo T, et al. Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. Horm Res Paediatr. 2010;73(6):473-6.

85. Costeira MJ, Oliveira P, Ares S, Roque S, de Escobar GM, Palha JA. Parameters of thyroid function throughout and after pregnancy in an iodine-deficient population. Thyroid. 2010 Sep;20(9):995-1001.

86. Drews K, Seremak-Mrozikiewicz A. The Optimal Treatment of Thyroid Gland Function Disturbances During Pregnancy. Curr Pharm Biotechnol.

87. Clarke N, Kabadi UM. Optimizing treatment of hypothyroidism.Treat Endocrinol. 2004;3(4):217-21.

88. Arnow WS. The heart and thyroid disease. Clin Geriatr Med. 1995May;11:219-29.

89. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ. 2001 Oct 20;323(7318):891-5.

90. Sesmilo G, Simó O, Choque L, et al. Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism. Endocrinol Nutr. Epub 2010 Dec 31.

91. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995 Dec;96(6):2828-38.

92. Escobar-Morreale HF, del Rey FE, Obregón MJ, de Escobar GM. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 1996 Jun;137(6):2490-502.

93. Sawaka AM, Gerstein HC, et al. Does a combination regimen of thyroxine (T4) and 3,5,3’-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind randomized, controlled trial. J Clin Endocrinol Metab. 2003 Oct;88(10):4551-5.

94. Walsh JP, Stuckey BG. What is the optimal treatment for hypothyroidism? Med J Aust. 2001Feb 5;174(3):41-3.

95. Dhal P et al. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008 Sep;5(3):170-6.

96. Gaby AR. Sub-laboratory hypothyroidism and the empirical use of Armour thyroid. Altern Med Rev. 2004 Jun;9(2):157-79.

97. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee.Thyroid. 2008 Mar;18(3):293-301.

98. Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med. 1992 Jan;152(1):183-4.

99. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992 Dec 15;117(12):1010-3.

100. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000 Jun 7;283(21):2822-5.

101. Bell DS, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract. 2001 May-Jun;7(3):193-4.

102. Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol. 2005 Sep;60(3):337-41.

103. Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010 Dec 13;170(22):1996-2003.

104 Delange F. Iodine deficiency in Europe and its consequences: an update. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S404-16.

105. de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. 2008;29(3):195-202.

106. Morton Salt. Available at: http://www.mortonsalt.com/faqs/food_salt_faq.html#q5. Accessed March 17, 2011.

107. Sidibé el H. [Reflections on mental retardation and congenital hypothyroidism: effects of trace mineral deficiencies]. Sante. 2007 Jan-Mar;17(1):41-50.

108. Delange F. The disorders induced by iodine deficiency. Thyroid. 1994 Spring;4(1):107-28.

109. de Escobar GM, Obregón MJ, del Rey FE. Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr. 2007 Dec;10(12A):1554-70.

110. Smallridge RC, Ladenson PW. Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab. 2001 Jun;86(6):2349-53.

111. Santiago-Fernandez P, Torres-Barahona R, Muela-Martínez JA, Rojo-Martínez G, García-Fuentes E, Garriga MJ, et al. Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab. 2004 Aug;89(8):3851-3857

112. Verkaik-Kloosterman J, van 't Veer P, Ocké MC. Reduction of salt: will iodine intake remain adequate in The Netherlands? Br J Nutr. 2010 Dec;104(11):1712-8.

113. Remer T, Neubert A, Manz F. Increased risk of iodine deficiency with vegetarian nutrition.Br J Nutr. 1999 Jan;81(1):45-9.

114. Krajcovicová-Kudlácková M, Bucková K, Klimes I, Seboková E. Iodine deficiency in vegetarians and vegans. Ann Nutr Metab. 2003;47(5):183-5.

115. Laurberg P, Bülow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid. 2001 May;11(5):457-69.

116. Duarte GC, Tomimori EK, de Camargo RY, et al. Excessive iodine intake and ultrasonographic thyroid abnormalities in schoolchildren. J Pediatr Endocrinol Metab. 2009 Apr;22(4):327-34.

117. Teas J, Braverman LE, Kurzer MS, et al. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food. 2007 Mar;10(1):90-100.

118. Miyai K, Kondo M, Tokushige T, et al. Suppression of thyroid function during ingestion of seaweed "Kombu" (Laminaria japonoca) in normal Japanese adults. Endocr J. 2008 Dec;55(6):1103-8.

119. Hetzel BS, Clugston GA. Iodine. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999:253-264.

120. Ghent WR, Eskin BA, Low DA, Hill LP. Iodine replacement in fibrocystic disease of the breast. Can J Surg. 1993;36(5):453-460.

121. Patrick L. Iodine: deficiency and therapeutic considerations. Altern Med Rev. 2008 Jun;13(2):116-27.

122. Kohrle J. The trace element selenium and the thyroid gland. Biochimie. 1999 May;81(5):527-33.

123. Kucharzewski M, Braziewicz J, Majewska U, Góźdź S. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res. 2002 Jul;88(1):25-30.

124. Rayman MP. The importance of selenium to human health. Lancet. 2000 Jul 15;356(9225):233-241.

125. Köhrle J. The trace element selenium and the thyroid gland. Biochimie. 1999 May;81(5):527-33.

126. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002 Oct;12(10):867-78.

127. Sidibé el H. Thyroid diseases in sub-Saharan Africa. Sante.2007 Jan-Mar;17(1):33-9.

128. Gladyshev VN. Selenoproteins and selenoproteomes. In: Hatfield DL, Berry MJ, Gladyshev VN, eds. Selenium: Its molecular biology and role in human health. 2nd ed. New York: Springer; 2006:99-114.

129. Mazokopakis EE, Chatzipavlidou V. Hashimoto's thyroiditis and the role of selenium. Current concepts. Hell J Nucl Med. 2007 Jan-Apr;10(1):6-8.

130. Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002 Apr;87(4):1687-91.

131. Karanikas G, Schuetz M, Kontur S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 2008 Jan;18(1):7-12.

132. Stazi AV, Trinti B. Selenium status and over-expression of interleukin-15 in celiac disease and autoimmune thyroid diseases. Ann Ist Super Sanita. 2010;46(4):389-399.

133. Gärtner R. Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. J Trace Elem Med Biol. 2009;23(2):71-4.

134. Angstwurm MW, Schopohl J, Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol. 2004 Jul;151(1):47-54.

135. Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab. 1994 Feb;78(2):288-91.

136. Kralik A, Eder K, Kirchgessner M. Influence of zinc and selenium deficiency on parameters relating to thyroid hormone metabolism. Horm Metab Res. 1996 May;28(5):223-6.

137. Nishiyama S, Futagoishi-Suginohara Y, Matsukura M, et al. Zinc supplementation alters thyroid hormone metabolism in disabled patients with zinc deficiency. J Am Coll Nutr. 1994 Feb;13(1):62-7.

138. Taneja SK, Mandal R. Beneficial effect of modified egg on serum T3, T4 and dyslipidaemia following dietary Zn-supplementation in Wistar rat. Indian J Exp Biol. 2008 Mar;46(3):171-9.

139. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20(1):3-18.

140. Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008 Aug 26;71(9):639-43.

141. Afrin LB. Fatal copper deficiency from excessive use of zinc-based denture adhesive. Am J Med Sci. 2010 Aug;340(2):164-8.

142. Duntas LH, Papanastasiou L, Mantzou E, Koutras DA. Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism. Exp Clin Endocrinol Diabetes. 1999;107(6):356-60.

143. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002 Oct;12(10):867-78.

144. Cinemre H, Bilir C, Gokosmanoglu F, Bahcebasi T. Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study. J Clin Endocrinol Metab. 2009 Jan;94(1):151-6.

145. Bastian TW, Prohaska JR, Georgieff MK, Anderson GW. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology. 2010 Aug;151(8):4055-65.

146. Sarandöl E, Taş S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct. 2005 Jan-Feb;23(1):1-8.

147. Oner J, Kükner A, Oner H, Ozan E, Yekeler H. Effect of vitamin E on follicular cell proliferation and expression of apoptosis-associated factors in rats with 6-N-propyl-2-thiouracil-induced goitrogenesis. Folia Histochem Cytobiol. 2003;41(4):213-7.

148. Goswami R, Marwaha RK, Gupta N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009 Aug;102(3):382-6.

149. Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W. The Prevalence of Vitamin D Deficiency Is Similar between Thyroid Nodule and Thyroid Cancer Patients. Int J Endocrinol. 2010;2010:805716.

150. Jabbar A, Yawar A, Waseem S, et al. Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc. 2008 May;58(5):258-61.

151. Morel S, Georges A, Bordenave L, Corcuff JB. Thyroid and gastric autoimmune diseases. Ann Endocrinol (Paris). 2009 Mar;70(1):55-8.

152. Tagawa N, Tamanaka J, Fujinami A, et al. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem. 2000 Apr;46(4):523-8.

153. Deshpande UR, Joseph LJ, Patwardhan UN, Samuel AM. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats. Indian J Exp Biol. 2002 Jun;40(6):735-8.

154. Subudhi U, Das K, Paital B, et al. Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats. Life Sci. 2009 Mar 13;84(11-12):372-9.

155. Zubeldia JM, Nabi HA, Del Río MJ, Genovese J. Exploring new applications for Rhodiola rosea: can we improve the quality of life of patients with short-term hypothyroidism induced by hormone withdrawal?J Med Food. 2010 Dec;13(6):1287-92. Epub 2010 Oct 14.

156. Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009 Sep;4(3):198-219. Epub 2009 Sep 1.

157. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones.Phytomedicine. 2009 Jun;16(6-7):617-22. Epub 2009 Feb 1.

158. Lakshmy R, Rao PS, Sesikeran B, Suryaprakash P. Lakshmy R, Rao PS, Sesikeran B, Suryaprakash P.Iodine metabolism in response to goitrogen induced altered thyroid status under conditions of moderate and high intake of iodine. Horm Metab Res. 1995 Oct;27(10):450-4.

159. Fenwick GR, Griffiths NM. The identification of the goitrogen (-)5-vinyloxazolidine-2-thione (goitrin), as a bitter principle of cooked brussels sprouts (Brassica oleracea L. var. gemmifera). Z Lebensm Unters Forsch. 1981 Feb;172(2):90-2.

160. Osman BA, Ng ML, Bakar AA, Khalid BA. The effect of cassava leave intake on thyroid hormone and urinary iodine.East Afr Med J. 1993 May;70(5):314-5.

161. Millet--a possibly goitrogenic cereal. Nutr Rev. 1983 Apr;41(4):113-6.

162. Greer MA Goitrogenic Substances in Food. Am J Clin Nutr. 1957Jul-Aug;5(4): 440-444.

163. Divi RL, Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol. 1996 Jan-Feb;9(1):16-23.

164. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997 Nov 15;54(10):1087-96.

165. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002 Jun;110 Suppl 3:349-53.

166. Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000 Nov 1;168(3):244-52.

167. Dillingham BL, McVeigh BL, Lampe JW, Duncan AM. Soy protein isolates of varied isoflavone content do not influence serum thyroid hormones in healthy young men. Thyroid. 2007 Feb;17(2):131-7.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.